Table 1.
Characteristics of Participants (n=150) from the Hawaii Aging with HIV - Cardiovascular Study Cohort
Characteristic | % or mean ± STD/median [IQR]where indicated |
---|---|
| |
Age, mean (yrs) | 52 |
| |
Female (%) | 12 |
| |
Tobacco-past (%) | 66 |
| |
Tobacco-current (%) | 25 |
| |
Viral load undetectable (< 48 copies/mm3) (%) | 85 |
| |
CD4 count, cell/mm3 | 524 |
| |
Nadir CD4 count, cell/mm3 | 167 |
| |
HAART (%) | 100 |
NRTI* | 96 |
NNRTI* | 51 |
PI* | 47 |
| |
Ethnicity (%) | |
White | 58 |
African American/Black | 4 |
Native American/Native Alaskan | 2 |
Pacific Islander | 1 |
Asian | 8 |
More than one race | 24 |
Unknown | 3 |
| |
Hypertension (%) | |
Total | 67 |
On medications | 76 (among total hypertensives) |
Diet controlled | 54 (among total hypertensives) |
| |
On lipid lowering medication | 31 |
| |
Diabetes (%) | 7 |
| |
HOMA-IR, mean ± STD | 2.53 ± 3.77 |
| |
Body Mass Index, kg/m2, mean ± STD | 26.5 ± 4.6 |
| |
Systolic blood pressure, mmHg, mean ± STD | 123 ± 16 |
| |
Diastolic blood pressure, mmHg, mean ± STD | 76 ± 10 |
| |
Total cholesterol, mg/dL, mean ± STD | 179.9 ± 40.3 |
| |
HDL cholesterol, mg/dL, mean ± STD | 44.5 ± 17.4 |
| |
LDL cholesterol, mg/dL, mean ± STD | 110 ± 35 |
| |
Triglycerides, mg/dL: median[IQR] | 117.5[87–168[ |
STD=Standard deviation
IQR=interquartile range
HOMA-IR- homeostasis model assessment of insulin resistance
NRTI=nucleoside/nucleotide reverse transcriptase inhibitor, NNRTI= non-nucleoside/nucleotide reverse transcriptase inhibitor, PI=protease inhibitor
not mutually exclusive, participants could be on more than one class